Carcinogenic and anticarcinogenic effects of dehydroepiandrosterone in the liver of male and female rats

References

• Baulieu E E. Studies of conjugated 17-ketosteroids in a case of adrenal tumor. J Clin Endocrinol Metab 1962; 22: 501–10
   PubMed Web of Science ®Google Scholar
• Orentreich N, Brind J L, Rizer R L, Vogelman J H. Age changes and sex differences in serum dehy-droepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 1984; 59: 551–5
   PubMed Web of Science ®Google Scholar
• Schwartz A G, Whitcomb J M, Nyce J W, Lewhart M L, Pashko L L. Dehydroepiandrosterone and structural analogs: a new class of cancer chemo-preventive agents. Adv Cancer Res 1988; 51: 391–424
   PubMed Web of Science ®Google Scholar
• Ebeling P, Kovisto V A. Physiological importance of dehydroepiandrosterone. Lancet 1994; 343: 1479–81
   PubMed Web of Science ®Google Scholar
• Herrington D M. Dehydroepiandrosterone (DHEA) and aging. Ann NY Acad Sci 1995; 774: 1–350, In Bellino FL, Daynes RA, Hornsby PS, Lavrin DH, Nestler JE, eds.
   Google Scholar
• Gordon G B, Shantz L M, Talalay P. Modulation of growth differentiation and carcinogenesis by dehydroepiandrosterone. Adv Enzyme Regul 1987; 26: 355–82
   Google Scholar
• Mayer D, Weber E, Bannasch P. Modulation of liver carcinogenesis by dehydroepiandrosterone. The Biologic Role of Dehydroepiandrosterone (DHEA), M Kalimi, W Regelson. Walter de Gruyter, BerlinGermany 1990; 361–85
   Google Scholar
• Metzger C, Mayer D, Hoffmann H, Bocker T, Hobe G, Benner A, Bannasch P. Sequential appearance and ultrastructure of amphophilic cell foci, adenomas, and carcinomas in the liver of male and female rats treated with dehydroepiandrosterone. Toxicol Pathol 1995; 23: 591–605
   PubMedGoogle Scholar
• Weber G. Enzymology of cancer cells, Parts 1 and 2. N Engl J Med 1977; 296: 486–93; 541–51
   PubMed Web of Science ®Google Scholar
• Klimek F, Mayer D, Bannasch P. Biochemical microanalysis of glycogen content and glucose-6-phosphate dehydrogenase activity in focal lesions of the rat liver induced by N-nitrosomorpholine. Carcinogenesis 1984; 5: 265–8
   PubMed Web of Science ®Google Scholar
• Stumpf H, Bannasch P. Overexpression ofglucose-6-phosphate dehydrogenase in rat hepatic preneo-plasia and neoplasia. Int J Oncol 1994; 5: 1255–60
   Google Scholar
• Van Werden E M, Bierings H G, Van Steenbrugge G J, de Jong F H, Schroder F H. Adrenal glands of the mouse and rat do not synthesize androgens. Life Sci 1992; 50: 857–61
   Google Scholar
• Hamilton S R, Gordon G B, Floyd J, Golightly S. Evaluation of dietary dehydroepiandrosterone for chemoprotection against tumorigenesis in premalignant colonic epithelium of male F 344 rats. Cancer Res 1991; 51: 476–80
   Google Scholar
• Hobe G, Hillesheim H G, Schon R, Reddersen G, Knappe R, Bannasch P, Mayer D. Sex differences in dehydroepiandrosterone metabolism in the rat: different plasma levels following ingestion of DHEA-supplemented diet and different metabolite patterns in plasma, bile and urine. Horm Metab Res 1994; 26: 326–9
   PubMedGoogle Scholar
• Sonka J. Dehydroepiandrosterone: metabolic effects. Acta Univ Carol Med 1976; 71: 1–171
   Google Scholar
• Leighton B, Tagliaferro A R, Newsholme E A. The effect of dehydroepiandrosterone acetate on liver peroxisomal enzyme activities of male and female rats. J Nutr 1987; 117: 1287–90
   PubMedGoogle Scholar
• Cleary M P, Shepherd A, Zisk J, Schwartz A. Effects of dehydroepiandrosterone on body weight and food intake in rats. Nutr Behav 1983; 1: 127–36
   Google Scholar
• Cleary M P, Hood S S, Chando C, Hansen C T, Billheimer J T. Response of sucrose-fed BHE rats to dehydroepiandrosterone. Nutr Res 1984; 4: 485–94
   Google Scholar
• Cleary M P, Shepherd A, Jenks B. Effect of dehydroepiandrosterone on growth in lean and obese Zucker rats. J Nutr 1984; 114: 1242–51
   PubMed Web of Science ®Google Scholar
• Cleary M P. Effect of dehydroepiandrosterone treatment on liver metabolism in rats. Int J Biochem 1990; 22: 205–10
   Google Scholar
• Mayer D, Reuter S, Hoffmann H, Bocker T, Bannasch P. Dehydroepiandrosterone reduces expression of glycolytic and gluconeogenic enzymes in the liver of male and female rats. Int J Oncol 1996; 8: 1069–78
   Google Scholar
• Mayer D, Weber E, Moore M A, Letsch I, Filsinger E, Bannasch P. Dehydroepiandrosterone (DHEA) induced alterations in rat liver carbohydrate metabolism. Carcinogenesis 1988; 11: 2039–49
   Google Scholar
• Hobe G, Hillesheim H G, Schon R, Ritter P, Reddersen G, Mayer D, Bannasch P. Sex differences in dehydroepiandrosterone (DHEA) metabolism in the rat. Proceedings of the 5th Symposium on Analysis of Steroids, S Gorog. Akademiai Kiado, BudapestHungary 1994; 383–90
   Google Scholar
• Schwartz A G. Inhibition of spontaneous breast cancer formation in female C3H (Avy/a) mice by long-term treatment with dehydroepiandrosterone. Cancer Res 1979; 15: 1269–74
   Google Scholar
• Ratko T A, Detrisac C J, Mehta R G, Kelloff G J, Moon R C. Inhibition of rat mammary gland chemical carcinogenesis by dietary dehydroepiandrosterone or a fluorinated analogue of dehydroepiandrosterone. Cancer Res 1991; 51: 481–6
   PubMed Web of Science ®Google Scholar
• Li S, Yan X, Belanger A, Labrie F. Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethyl-benzanthracene (DMBA) in the rat. Breast Cancer Res Treat 1993; 29: 203–17
   Web of Science ®Google Scholar
• McCormick D L, Rao K VN, Johnson W D, Bowman-Gram T A, Steele V E, Lubet R A, Kelloff G J. Exceptional chemopreventive activity of low-dose dehydroepiandrosterone in the rat mammary gland. Cancer Res 1996; 56: 1724–6
   PubMed Web of Science ®Google Scholar
• Pashko L L, Rovito R T, Williams J R, Sobel E L, Schwartz A G. Dehydroepiandrosterone (DHEA) and 3β-methylandrost-5-en-17-one: inhibitors of 7,12-dimethylbenz‘a’anthracene (DMBA)-initiated and 12–0-tetradecanoyl-phorbol-13-acetate (TPA)-promoted skin papilloma formation in mice. Carcinogenesis 1984; 5: 463–6
   PubMed Web of Science ®Google Scholar
• Schwartz A G, Fairman D K, Polansky M, Lewbart M L, Pashko L L. Inhibition of 7,12-dimethyl-benz‘a’anthracene-initiated and 12-O-tetradeca-noylphorbol-13-acetate-promoted skin papilloma formation in mice by dehydroepiandrosterone and two synthetic analogs. Carcinogenesis 1989; 10: 1809–13
   PubMedGoogle Scholar
• Nyce J W, Magee P N, Hard G C, Schwartz A G. Inhibition of 1,2-dimethylhydrazine-induced colon tumorigenesis in Balb/c mice by dehydroepiandrosterone. Carcinogenesis 1984; 5: 57–62
   PubMed Web of Science ®Google Scholar
• Schwartz A G, Tannen R H. Inhibition of 7,12-dimethylbenz‘a’anthracene and urethane-induced lung tumor formation in A/J mice by long-term treatment with dehydroepiandrosterone. Carcinogenesis 1981; 2: l335–7
   Google Scholar
• Moore M A, Thamavit W, Tsuda H, Sato K, Ichihara A, Ito N. Modifying influence of dehydroepiandrosterone on the development of dihydroxydi-n-propylnitrosamine-initiated lesions in the thyroid, lung and liver of F344 rats. Carcinogenesis 1986; 7: 311–16
   PubMed Web of Science ®Google Scholar
• Bannasch P. Pathogenesis of hepatocellular carcinoma: sequential cellular, molecular, and metabolic changes. Progress in Liver Disease, J L Boyer, R K Ockner. WB Saunders Company, PhiladelphiaUSA 1996; XIV: 161–97
   Google Scholar
• Weber E, Moore M A, Bannasch P. Enzyme histo-chemical and morphological phenotype of amphophilic foci and amphophilic/tigroid cell adenomas in rat liver after combined treatment with dehydroepiandrosterone and N-nitrosomorpho-line. Carcinogenesis 1988; 9: 1049–54
   Google Scholar
• Bannasch P, Klimek F, Mayer D. Early bio-energetic changes in hepatocarcinogenesis: preneoplastic phenotypes mimic responses to insulin and thyroid hormone. J Bioenerg Biomemb 1997; 29: 303–13
   Google Scholar
• Garcea R, Daino L, Pascale R, Frassetto S, Coz-zolino P, Ruggiu M E, Feo F. Inhibition by dehydroepiandrosterone of liver preneoplastic foci formation in rats after initiation-selection in experimental carcinogenesis. Toxicol Pathol 1987; 15: 164–9
   PubMed Web of Science ®Google Scholar
• Garcea R, Daino L, Frassetto S, Cozzolino P, Ruggiu M E, Vannini M G, Pascale R, Lenzerini L, Simile M M, Puddu M, Feo F. Reversal by ribo-and deoxyribonucleosides of dehydroepiandros-terone-induced inhibition of enzyme altered foci in the liver of rats subjected to the initiation-selection process of experimental hepatocarcinogenesis. Carcinogenesis 1988; 9: 931–8
   Google Scholar
• Thornton M, Moore M A, Ito N. Modifying influence of dehydroepiandrosterone or butylated hydroxytoluene treatment on initiation and development stages of azaserine-induced acinar pancreatic lesions in the rat. Carcinogenesis 1989; 10: 407–10
   Google Scholar
• Weber E, Moore M, Bannasch P. Phenotypic modulation of hepatocarcinogenesis and reduction in N-nitrosomorpholine-induced hemangiosar-coma and adrenal lesion development in Sprague-Dawley rats by dehydroepiandrosterone. Carcinogenesis 1988; 9: 1191–5
   PubMedGoogle Scholar
• Moore M A, Weber E, Bannasch P. Modulating influence of dehydroepiandrosterone administration on the morphology and enzyme phenotype of dimethylaminoazobenzene-induced hepatocellular foci and nodules. Virchows Arch B Cell Pathol 1988; 55: 337–43
   Google Scholar
• Rao M S, Subbarao V, Kumar S, Yeldandi V, Reddy J K. Phenotypic properties of liver tumors induced by dehydroepiandrosterone in F-344 rats. Jpn J Cancer Res 1992; 83: 1179–83
   PubMedGoogle Scholar
• Rao M S, Subbarao V, Yeldandi A V, Reddy J K. Hepatocarcinogenicity of dehydroepiandrosterone in the rat. Cancer Res 1992; 52: 2977–9
   PubMed Web of Science ®Google Scholar
• Hayashi F, Tamura H, Yamada J, Kasai H, Suga T. Characteristics of the hepatocarcinogenesis caused by dehydroepiandrosterone, a peroxisome prolifer-ator, in male F-344 rats. Carcinogenesis 1994; 15: 2215–19
   PubMed Web of Science ®Google Scholar
• Metzger C, Bannasch P, Mayer D. Enhancement and phenotypic modulation of N-nitrosomorpholine-induced hepatocarcinogenesis by dehydroepiandrosterone. Cancer Letters 1998, in press
   Google Scholar
• Moore M A, Weber E, Thornton M, Bannasch P. Sex-dependent, tissue-specific opposing effects of dehydroepiandrosterone on initiation and modulation stages of liver and lung carcinogenesis induced by dihydroxy-di-n-propylnitrosamine in F344 rats. Carcinogenesis 1988; 9: 1507–9
   PubMedGoogle Scholar
• Ogiu T, Hard G C, Schwartz A G, Magee P N. Investigation into the effect on renal carcinogenesis induced in the rat by a single dose of DMN. Nutr Cancer 1990; 14: 57–67
   PubMed Web of Science ®Google Scholar
• Reuter S, Mayer D. Transport of dehydroepian-drosterone and dehydroepiandrosterone sulphate into rat hepatocytes. J Steroid Biochem Molec Biol 1995; 54: 227–35
   Google Scholar
• Swierczynski J, Bannasch P, Mayer D. Increase of lipid peroxidation in rat liver microsomes by dehydroepiandrosterone feeding. Biochim Biophys Acta 1996; 1315: 193–8
   PubMedGoogle Scholar
• Swierczynski J, Mayer D. Dehydroepian-drosterone-induced lipid peroxidation in rat liver mitochondria. J Steroid Biochem Molec Biol 1996; 58: 599–603
   PubMed Web of Science ®Google Scholar
• Swierczynski J, Kochan Z, Mayer D. Dietary α-tocopherol prevents dehydroepiandrosterone-induced lipid peroxidation in rat liver microsomes and mitochondria. Toxicol Letters 1997; 91: 129–36
   PubMedGoogle Scholar
• Wu H, Masset-Brown J, Tweedie D J, Milewich L, Frenkel R A, Martin-Wixtrom C, Estabrook D W, Prough R A. Induction of microsomal NADPH-cytochrome P-450 reductase and cytochrome P-450 IVAI (P-450laco) by dehydroepiandrosterone in rats: a possible peroxisome proliferator. Cancer Res 1989; 49: 2337–43
   PubMed Web of Science ®Google Scholar
• Prough R A, Webb S J, Wu H-Q, Lapenson D P, Waxman D J. Induction of microsomal and peroxisomal enzymes by dehydroepiandrosterone and its reduced metabolite in rats. Cancer Res 1994; 54: 2878–86
   PubMed Web of Science ®Google Scholar
• Beier K, Völkl A, Metzger C, Mayer D, Bannasch P, Fahimi H D. Hepatic zonation of the induction of cytochrome P450 IVA, peroxisomal lipid peroxidation enzymes and peroxisome proliferation in rats treated with dehydroepiandrosterone (DHEA). Evidence of distinct zonal and sex-specific differences. Carcinogenesis 1997; 18: 1491–8
   Google Scholar
• Rao M S, Reid B, Ide H, Subbarao V, Reddy J K. Dehydroepiandrosterone-induced peroxisome proliferation in the rat: evaluation of sex differences. Proc Soc Exp Biol Med 1994; 207: 186–90
   PubMed Web of Science ®Google Scholar
• Frenkel R A, Slaughter C A, Orth K, Moomaw C R, Hicks S H, Snyder J M, Bennet M, Prough R A, Putnam R S, Milewich L. Peroxisome proliferation and induction of peroxisomal enzymes in mouse and rat liver by dehydroepiandrosterone feeding. J Steroid Biochem 1990; 35: 333–42
   Google Scholar
• Yamada J, Sakuma M, Ikeda T, Fukuda K, Suga T. Characteristics of dehydroepiandrosterone as a peroxisome proliferator. Biochim Biophys Acta 1991; 1092: 233–43
   PubMed Web of Science ®Google Scholar
• Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature (London) 1990; 347: 645–50
   PubMed Web of Science ®Google Scholar
• Green S. Receptor-mediated mechanisms of peroxisome proliferators. Biochem Pharmacol 1992; 43: 393–401
   PubMed Web of Science ®Google Scholar
• Reddy J K, Lalwani N D. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Crit Rev Toxicol 1983; 12: 1–58
   PubMed Web of Science ®Google Scholar
• Hawkins J M, Jones W E, Bonner F W, Gibson G G. The effect of peroxisome proliferators on microsomal, peroxisomal, and mitochondrial enzyme activities in the liver and kidney. Drug Metab Rev 1987; 18: 441–515
   PubMed Web of Science ®Google Scholar
• Yamada J, Sakuma M, Ikeda T, Suga T. Activation of dehydroepiandrosterone as a peroxisome proliferator by sulfate conjugation. Arch Biochem Biophys 1994; 313: 379–81
   Google Scholar
• Sakuma M, Yamada J, Suga T. Induction of peroxisomal β-oxidation by structural analogues of dehydroepiandrosterone in cultured rat hepatocytes: structure-activity relationships. Biochim Biophys Acta 1993; 1169: 66–72
   PubMedGoogle Scholar
• Yamada J, Sugiyama H, Tamura H, Suga T. Hormonal modulation of peroxisomal enzyme induction caused by peroxisome proliferators: suppression by growth and thyroid hormones in cultured rat hepatocytes. Arch Biochem Biophys 1994; 315: 555–7
   Google Scholar